News About: Pharm. Industry
Intensified generic-based management in Korean pharmaceutical industry
Korean pharmaceutical companies were criticized to still manage their business relying on generic drugs. 3 of 4 medicines approved this year were ETC, and most ETC drugs were reportedly generics Korean pharmaceutical ...
Public pharmaceutical companies with largest merchandise sales
Both KOSPI and KOSDAQ pharmaceutical companies had a significant increase of collective merchandise sales by this 3rd quarter year-on-year. When it comes to merchandise sales/total sales ratio, KOSPI pharmaceutical co...
Hanmi Pharm, Celltrion and Samsung Biologics in order for brand reputation
According to the Listed Pharmaceutical Company Brand Reputation Research for December 2017, it was analyzed Hanmi Pharm, Celltrion and Samsung Biologics were on the 1st, 2nd and 3rd respectively.
The Korea Reputation...
‘Hot potato’ over changes in the list of emergency household medicines before 5th deliberative committee
Will new products be included in the list of emergency household medicines? Or won’t there be no major change?
While the 5th meeting will be the final one to adjust the products, the pharmaceutical association has cr...
Which pharmaceutical companies spent the most in R&D?
KOSPI pharmaceutical companies increased collective R&D expenses by this 3rd quarter year-on-year, but KOSDAQ pharmaceutical companies had a decrease. When it comes to the collective 3rd quarter’s R&D expense/sales ra...
Rapid decrease of bioequivalently-recognized medicines shows pharmaceutical companies’ hesitation over generic development
Medicines which have been newly recognized in bioequivalence test this year were 481 products, the number was decreased by almost a half compared to the last year’s same time of period.
According to the Ministry of F...
Pharmaceutical companies’ ‘two-faced’ viewpoint towards ISO37001
‘Will they move?”
The industry has paid attention to whether pharmaceutical companies will be active on the ISO 37001 certification process the Pharmaceutical and Bio-Pharma Manufacturers Association adopted as part ...
Sanofi starts Phase III clinical trial for efpeglenatide exported from Hanmi Pharm
A Phase III clinical trial for ‘efpeglenatide’ developed by Hanmi Pharm on its own and whose technology was transferred to Sanofi, a global pharmaceutical company, will start on 4 December.
On the 28th(local Korea ti...
1 of 4 listed pharmas with unsound financial structure
1 of 4 listed pharmaceutical companies were criticized as a company with poor financial structure as recording a debt rate higher than 100%.
Yakup Shinmoon(www.yakup.com) analyzed 2017 3rd quarter reports turned in b...
Listed pharmas’ overseas sales & exports
KOSDAQ pharmaceutical companies reportedly recorded a percentage of foreign sales/exports to collective sales in the 3rd quarter of this year, which is twice higher than the one recorded by KOSPI pharmaceutical compan...
